Found: 63
Select item for more details and to access through your institution.
A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Testicular sarcoidosis with bilateral scrotal swelling.
- Published in:
- IJU Case Reports, 2020, v. 3, n. 1, p. 12, doi. 10.1002/iju5.12124
- By:
- Publication type:
- Article
A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin.
- Published in:
- BJU International, 2011, v. 108, n. 6, p. 831, doi. 10.1111/j.1464-410X.2010.09933.x
- By:
- Publication type:
- Article
A randomized clinical trial of suspension technique for improving early recovery of urinary continence after radical retropubic prostatectomy.
- Published in:
- BJU International, 2008, v. 102, n. 8, p. 958, doi. 10.1111/j.1464-410X.2008.07759.x
- By:
- Publication type:
- Article
Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Malignant lymphoma of the bladder with bilateral hydronephrosis.
- Published in:
- Rare Tumors, 2019, v. 11, p. 1, doi. 10.1177/2036361318825165
- By:
- Publication type:
- Article
Malignant lymphoma of the bladder with bilateral hydronephrosis.
- Published in:
- Rare Tumors, 2019, v. 11, p. 1, doi. 10.1177/2036361318825165
- By:
- Publication type:
- Article
A case of primary mucosa-associated lymphoid tissue lymphoma of the prostate.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms.
- Published in:
- Asian Journal of Andrology, 2008, v. 10, n. 5, p. 777, doi. 10.1111/j.1745-7262.2008.00361.x
- By:
- Publication type:
- Article
Effect of an extract of Ganoderma lucidum in men with lower urinary tract symptoms: a double-blind, placebo-controlled randomized and dose-ranging study.
- Published in:
- Asian Journal of Andrology, 2008, v. 10, n. 4, p. 651, doi. 10.1111/j.1745-7262.2008.00336.x
- By:
- Publication type:
- Article
A questionnaire survey of patient preparation and techniques for prostate biopsy among urologists in the Kyushu and Okinawa regions of Japan.
- Published in:
- International Journal of Clinical Oncology, 2006, v. 11, n. 5, p. 390, doi. 10.1007/s10147-006-0592-3
- By:
- Publication type:
- Article
Target molecules in specific immunotherapy against prostate cancer.
- Published in:
- International Journal of Clinical Oncology, 2003, v. 8, n. 4, p. 193, doi. 10.1007/s10147-003-0332-x
- By:
- Publication type:
- Article
Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Necessity of repeat biopsies in men for suspected prostate cancer.
- Published in:
- International Journal of Urology, 1999, v. 6, n. 1, p. 7, doi. 10.1046/j.1442-2042.1999.00611.x
- By:
- Publication type:
- Article
Therapeutic Efficacy of Clenbuterol for Urinary Incontinence after Radical Prostatectomy.
- Published in:
- International Journal of Urology, 1997, v. 4, n. 5, p. 480, doi. 10.1111/j.1442-2042.1997.tb00289.x
- By:
- Publication type:
- Article
Detection of Circulating Tumor Cells in Patients with Prostate Cancer Using Prostate Specific Membrane-Derived Primers in the Polymerase Chain Reaction.
- Published in:
- International Journal of Urology, 1997, v. 4, n. 4, p. 374, doi. 10.1111/j.1442-2042.1997.tb00211.x
- By:
- Publication type:
- Article
Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0075463
- By:
- Publication type:
- Article
Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 847, doi. 10.1007/s00262-020-02498-8
- By:
- Publication type:
- Article
Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1223, doi. 10.1007/s00262-016-1887-5
- By:
- Publication type:
- Article
A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 151, doi. 10.1007/s00262-015-1781-6
- By:
- Publication type:
- Article
Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1565, doi. 10.1007/s00262-015-1756-7
- By:
- Publication type:
- Article
Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 493, doi. 10.1007/s00262-015-1660-1
- By:
- Publication type:
- Article
Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 919, doi. 10.1007/s00262-012-1379-1
- By:
- Publication type:
- Article
A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1001, doi. 10.1007/s00262-010-0822-4
- By:
- Publication type:
- Article
An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 alleles.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1879, doi. 10.1007/s00262-009-0699-2
- By:
- Publication type:
- Article
Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 689, doi. 10.1007/s00262-006-0216-9
- By:
- Publication type:
- Article
Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2<sup>+</sup> patients with hormone-refractory prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 6, p. 479, doi. 10.1007/s00262-003-0464-x
- By:
- Publication type:
- Article
Assessment of morphometric measurements of prostate carcinoma volume.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer.
- Published in:
- Cancer Science, 2004, v. 95, n. 1, p. 77, doi. 10.1111/j.1349-7006.2004.tb03174.x
- By:
- Publication type:
- Article
Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24<sup>+</sup> prostate cancer patients.
- Published in:
- Cancer Science, 2003, v. 94, n. 7, p. 622, doi. 10.1111/j.1349-7006.2003.tb01493.x
- By:
- Publication type:
- Article
Stereospecific synthesis of a family of novel ( E)-2-aryl-1-silylalka-1,4-dienes or ( E)-4-aryl-5-silylpenta-1,2,4-trienes via a cross-coupling of ( Z)-silyl(stannyl)ethenes with allyl halides or propargyl bromide.
- Published in:
- Applied Organometallic Chemistry, 2008, v. 22, n. 2, p. 128, doi. 10.1002/aoc.1360
- By:
- Publication type:
- Article
Recent Advances in Cancer Vaccines: An Overview.
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 2, p. 73
- By:
- Publication type:
- Article
Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy.
- Published in:
- Prostate, 2012, v. 72, n. 8, p. 834, doi. 10.1002/pros.21485
- By:
- Publication type:
- Article
A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer.
- Published in:
- Prostate, 2011, v. 71, n. 5, p. 470, doi. 10.1002/pros.21261
- By:
- Publication type:
- Article
Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients.
- Published in:
- Prostate, 2008, v. 68, n. 16, p. 1753, doi. 10.1002/pros.20847
- By:
- Publication type:
- Article
Immunological evaluation of neoadjuvant peptide vaccination before radical prostatectomy for patients with localized prostate cancer.
- Published in:
- Prostate, 2007, v. 67, n. 9, p. 933, doi. 10.1002/pros.20572
- By:
- Publication type:
- Article
New epitope peptides derived from parathyroid hormone-related protein which have the capacity to induce prostate cancer-reactive cytotoxic T lymphocytes in HLA-A2+ prostate cancer patients.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 233, doi. 10.1002/pros.20133
- By:
- Publication type:
- Article
Identification of polycomb group protein enhancer of zeste homolog 2 (EZH2)‐derived peptides immunogenic in HLA‐A24+ prostate cancer patients.
- Published in:
- Prostate, 2004, v. 60, n. 4, p. 273, doi. 10.1002/pros.20078
- By:
- Publication type:
- Article
Immunological monitoring during combination of patient-oriented peptide vaccination and estramustine phosphate in patients with metastatic hormone refractory prostate cancer.
- Published in:
- Prostate, 2004, v. 60, n. 1, p. 32, doi. 10.1002/pros.20011
- By:
- Publication type:
- Article
Prostate-specific antigen-derived epitopes capable of inducing cellular and humoral responses in HLA-A24<sup>+</sup> prostate cancer patients.
- Published in:
- Prostate, 2003, v. 57, n. 2, p. 152, doi. 10.1002/pros.10280
- By:
- Publication type:
- Article
Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination.
- Published in:
- Prostate, 2003, v. 57, n. 1, p. 80, doi. 10.1002/pros.10276
- By:
- Publication type:
- Article
Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients.
- Published in:
- International Journal of Oncology, 2020, v. 56, n. 6, p. 1479, doi. 10.3892/ijo.2020.5019
- By:
- Publication type:
- Article
Clinical development of immunotherapy for prostate cancer.
- Published in:
- International Journal of Urology, 2017, v. 24, n. 9, p. 675, doi. 10.1111/iju.13397
- By:
- Publication type:
- Article
Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
- Published in:
- International Journal of Urology, 2007, v. 14, n. 8, p. 713, doi. 10.1111/j.1442-2042.2007.01809.x
- By:
- Publication type:
- Article
Evaluation of a prostate biopsy strategy for cancer detection using a computer simulation system with virtual needle biopsy for three-dimensional prostate models.
- Published in:
- International Journal of Urology, 2006, v. 13, n. 10, p. 1296, doi. 10.1111/j.1442-2042.2006.01561.x
- By:
- Publication type:
- Article
Urodynamic evaluation of a suspension technique for rapid recovery of continence after radical retropubic prostatectomy.
- Published in:
- International Journal of Urology, 2006, v. 13, n. 4, p. 373, doi. 10.1111/j.1442-2042.2006.01313.x
- By:
- Publication type:
- Article
Early catheter removal 3 days after radical retropubic prostatectomy.
- Published in:
- International Journal of Urology, 2004, v. 11, n. 11, p. 983, doi. 10.1111/j.1442-2042.2004.00935.x
- By:
- Publication type:
- Article
Chemohormonal therapy as primary treatment for metastatic prostate cancer: A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist
- Published in:
- International Journal of Urology, 2004, v. 11, n. 2, p. 103, doi. 10.1111/j.1442-2042.2004.t01-1-00748.x
- By:
- Publication type:
- Article
Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 12, p. 3208, doi. 10.1002/cncr.26636
- By:
- Publication type:
- Article